Key facts
- Puncture Robotic’s last known valuation is $13.9M (Jan 2021).
- It has raised $31.5M; the latest was Later Stage VC ($14.5M) in Apr 2026.
- Notable investors include Shenzhen Capital Group, Guoyao Venture Capital, Lenovo Capital and Incubator Group, Hefei Innovation Technology Venture Capital, Jolmo Investment — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Puncture Robotic
- ·The full record, as it builds
Funding rounds
No funding rounds for Puncture Robotic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Puncture Robotic
Developer of venipuncture robots designed to provide a series of automation, informatization and intelligent solutions for medical institutions. The company's robots focus on real-time image navigation for soft tissue intervention, which are applied to the fields of percutaneous puncture, such as thoracoabdominal and pelvic tumors and medical aesthetics and can also conduct blood collection without human intervention, providing hospitals and health organizations with affordable medical robots.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Website
- pangce.com.cn/
- Ownership
- Privately Held (backing)
Puncture Robotic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Puncture Robotic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Puncture Robotic in its N-PORT filings yet. We sweep new filings monthly.